2015
- 01/09/2015 Significant shares
- 01/20/2015 Increase and decrease in share capital
- 02/11/2015 Patent application Neol
- 02/17/2015 Notice of call Extraordinary General Shareholder´s Meeting
- 02/25/2014 Information on capital increase
- 02/26/2015 American Patent Simvastatin
- 03/06/2015 Capital Increase BORME
- 03/16/2015 licences, patents and products
- 03/19/2015 Clamber Proyect Neol
- 03/23/2015 Business Plan and valuation
- 03/24/2015 Agreements at EGSM
- 04/10/2015 Increase and decrease in share capital
- 04/22/2015 More information on financial operations
- 05/13/2015 Notice of call General Shareholder´s Meeting
- 05/19/2015 R+D: Results
- 07/07/2015 Information on shareholders
- 08/26/2015 licences, patents and products
- 09/21/2015 licences, patents and products
- 09/23/2015 licences, patents and products
- 10/15/2015 More information on financial operations
- 10/21/2015 Other businesses and financial situations
- 10/27/2015 More information on financial operations
- 11/05/2015 Other businesses and finantial situations
- 11/16/2015 More information on financial operations
- 12/14/2015 Increase or reduction of share capital
- 12/22/2014 Financial Information
2014
- 01/10/2014 Significant shares
- 02/25/2014 Removal Director Appointment
- 04/29/2014 Publication capital increase BORME
- 05/29/2014 Call to the General Shareholder´s Meeting
- 05/29/2014 Presentation Foro Medcap 2014
- 06/09/2014 licences, patents and products
- 06/09/2014 Results capital increase
- 06/10/2014 licences, patents and products
- 07/01/2014 General Shareholder´s Meeting cancelled
- 07/04/2014 Significant shares
- 07/08/2014 General Shareholder´s Meeting announcement
- 07/25/2014 Agreements at OGSM
- 09/26/2014 Change of corporate name
- 09/30/2014 Commercial agreement
- 10/01/2014 Resignation of a director
- 10/21/2014 Resignation of board director Neol
- 10/29/2014 Clarification RF dated 10/21/14
- 10/30/2014 licences, patents and products
- 11/27/2014 Change of certifed Financial Planner
- 12/01/2014 Appointment javier Tallada
- 12/02/2014 licences, patents and products
- 12/12/2014 News on Confidencial media
- 12/18/2014 Agreement Neuron Repsol
- 12/29/2014 licences, patents and products
2012
2011
2010
Invertir en Neuron Bio
Si esta interesado en adquirir acciones de Neuron Bio, puede ponerse en contacto con intermediarios especializados que puedan operar en Bolsa. Estos intermediarios son entidades financieras, Sociedades de Valores y Bolsa y Agencias de Valores y Bolsa. Para cualquier duda sobre cómo invertir en Neuron Bio, puede contactar con nosotros.
